Vanguard Group’s OrthoPediatrics KIDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $17.2M | Buy |
970,445
+9,115
| +0.9% | +$160K | ﹤0.01% | 2684 |
|
|
2025
Q3 | $17.8M | Buy |
961,330
+10,927
| +1% | +$225K | ﹤0.01% | 2683 |
|
|
2025
Q2 | $20.4M | Buy |
950,403
+12,434
| +1% | +$269K | ﹤0.01% | 2546 |
|
|
2025
Q1 | $23.1M | Buy |
937,969
+14,079
| +2% | +$348K | ﹤0.01% | 2446 |
|
|
2024
Q4 | $21.4M | Sell |
923,890
-32,165
| -3% | -$804K | ﹤0.01% | 2554 |
|
|
2024
Q3 | $25.9M | Buy |
956,055
+47,474
| +5% | +$1.44M | ﹤0.01% | 2468 |
|
|
2024
Q2 | $26.1M | Buy |
908,581
+24,754
| +3% | +$759K | ﹤0.01% | 2440 |
|
|
2024
Q1 | $25.8M | Buy |
883,827
+11,100
| +1% | +$310K | ﹤0.01% | 2470 |
|
|
2023
Q4 | $28.4M | Buy |
872,727
+11,923
| +1% | +$346K | ﹤0.01% | 2439 |
|
|
2023
Q3 | $27.5M | Buy |
860,804
+10,861
| +1% | +$418K | ﹤0.01% | 2413 |
|
|
2023
Q2 | $37.3M | Buy |
849,943
+13,263
| +2% | +$612K | ﹤0.01% | 2321 |
|
|
2023
Q1 | $37.1M | Buy |
836,680
+39,798
| +5% | +$1.76M | ﹤0.01% | 2307 |
|
|
2022
Q4 | $31.7M | Buy |
796,882
+8,351
| +1% | +$348K | ﹤0.01% | 2395 |
|
|
2022
Q3 | $36.4M | Buy |
788,531
+30,333
| +4% | +$1.49M | ﹤0.01% | 2335 |
|
|
2022
Q2 | $32.7M | Buy |
758,198
+32,015
| +4% | +$1.46M | ﹤0.01% | 2399 |
|
|
2022
Q1 | $39.2M | Sell |
726,183
-6,182
| -0.8% | -$316K | ﹤0.01% | 2425 |
|
|
2021
Q4 | $43.8M | Buy |
732,365
+2,761
| +0.4% | +$172K | ﹤0.01% | 2426 |
|
|
2021
Q3 | $47.8M | Sell |
729,604
-1,012
| -0.1% | -$65.7K | ﹤0.01% | 2389 |
|
|
2021
Q2 | $46.2M | Buy |
730,616
+23,764
| +3% | +$1.37M | ﹤0.01% | 2418 |
|
|
2021
Q1 | $34.5M | Buy |
706,852
+16,831
| +2% | +$808K | ﹤0.01% | 2508 |
|
|
2020
Q4 | $28.5M | Buy |
690,021
+48,640
| +8% | +$2.23M | ﹤0.01% | 2469 |
|
|
2020
Q3 | $29.5M | Sell |
641,381
-15,591
| -2% | -$723K | ﹤0.01% | 2281 |
|
|
2020
Q2 | $28.7M | Buy |
656,972
+103,837
| +19% | +$4.67M | ﹤0.01% | 2259 |
|
|
2020
Q1 | $21.9M | Buy |
553,135
+22,812
| +4% | +$1.02M | ﹤0.01% | 2240 |
|
|
2019
Q4 | $24.9M | Buy |
530,323
+65,139
| +14% | +$2.52M | ﹤0.01% | 2422 |
|
|
2019
Q3 | $16.4M | Buy |
465,184
+7,538
| +2% | +$261K | ﹤0.01% | 2577 |
|
|
2019
Q2 | $17.8M | Buy |
457,646
+20,799
| +5% | +$839K | ﹤0.01% | 2571 |
|
|
2019
Q1 | $19.3M | Buy |
436,847
+15,262
| +4% | +$581K | ﹤0.01% | 2525 |
|
|
2018
Q4 | $14.7M | Buy |
421,585
+102,032
| +32% | +$3.23M | ﹤0.01% | 2588 |
|
|
2018
Q3 | $11.7M | Buy |
319,553
+28,073
| +10% | +$860K | ﹤0.01% | 2837 |
|
|
2018
Q2 | $7.76M | Buy |
291,480
+119,100
| +69% | +$2.54M | ﹤0.01% | 3026 |
|
|
2018
Q1 | $2.6M | Buy |
172,380
+34,537
| +25% | +$611K | ﹤0.01% | 3368 |
|
|
2017
Q4 | $2.65M | Buy |
+137,843
| New | +$2.64M | ﹤0.01% | 3340 |
|
Other funds holding KIDS
B
GIM
SCM
BCM
Vanguard Group's KIDS Position: Q4 2025 in Review
Vanguard Group increased its OrthoPediatrics (KIDS) stake by 0.95% in Q4 2025, buying an estimated $160K and bringing the position to 970,445 shares worth $17.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2684.
Vanguard Group first reported a position in KIDS in Q4 2017 and has held it in 33 quarters since. The position peaked at $47.8M in Q3 2021. 120 funds tracked by Wall St. Rank hold KIDS as of Q4 2025.
- Vanguard Group held 970,445 shares of OrthoPediatrics worth $17.2M as of Q4 2025.
- Vanguard Group bought 9,115 OrthoPediatrics shares in Q4 2025, an estimated $160K.
- OrthoPediatrics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2684 holding.
- Vanguard Group first reported a position in OrthoPediatrics in Q4 2017 and has held it in 33 quarters since.
- Vanguard Group's OrthoPediatrics position peaked at $47.8M in Q3 2021.
- 120 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.